Aspen agrees deal to manufacture Johnson & Johnson’s Covid-19 vaccine candidate

Aspen has entered into a preliminary agreement to manufacture Johnson & Johnson’s COVID-19 vaccine candidate, if it does become successful. The vaccine candidate is currently undergoing clinical trials. Stavros Nicolaou, Senior Executive for Strategic Trade at Aspen joins CNBC Africa for more.

Thu, 05 Nov 2020 10:08:38 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.